Hao Xiong Selected Research

P 536

7/2020

Effect of hyperuricemia on functional outcomes and complications in patients with elbow stiffness after open arthrolysis combined with hinged external fixation: a retrospective study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hao Xiong Research Topics

Disease

41	Neoplasms (Cancer) 04/2024 - 09/2010
23	Hearing Loss (Hearing Impairment) 05/2024 - 06/2006
8	Thrombocytopenia (Thrombopenia) 01/2023 - 12/2010
7	Noise-Induced Hearing Loss (Acoustic Trauma) 12/2023 - 09/2016
7	Wounds and Injuries (Trauma) 05/2023 - 02/2013
7	Infections 04/2023 - 12/2009
7	Ototoxicity 10/2021 - 01/2006
7	Tinnitus 01/2020 - 01/2013
5	Body Weight (Weight, Body) 01/2024 - 10/2015
5	Osteoarthritis 12/2023 - 01/2022
5	Inflammation (Inflammations) 12/2023 - 11/2018
5	Drug-Related Side Effects and Adverse Reactions 08/2023 - 09/2018
4	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2023 - 08/2021
4	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 11/2017
4	Breast Neoplasms (Breast Cancer) 10/2022 - 01/2018
4	Sensorineural Hearing Loss 10/2021 - 03/2010
4	Stevens-Johnson Syndrome (Lyell's Syndrome) 07/2021 - 02/2018
4	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 07/2017
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2024 - 10/2021
3	Leukemia 02/2024 - 12/2011
3	Bone Diseases (Bone Disease) 01/2024 - 12/2015
3	Aplastic Anemia (Anemia, Hypoplastic) 01/2024 - 08/2021
3	Multiple Myeloma 01/2024 - 01/2021
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2023 - 12/2020
3	Fibrosis (Cirrhosis) 05/2023 - 01/2019
3	Neutropenia 01/2023 - 07/2014
3	Carcinoma (Carcinomatosis) 01/2023 - 01/2018
3	Leukopenia 01/2023 - 07/2014
3	Fatigue 12/2022 - 04/2015
3	Disease Progression 10/2022 - 10/2018
3	COVID-19 01/2022 - 01/2020
3	Deafness (Deaf Mutism) 01/2019 - 05/2007
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 07/2014
3	Nausea 11/2016 - 04/2015
2	Residual Neoplasm 02/2024 - 04/2022
2	Thrombotic Microangiopathies 01/2024 - 08/2023
2	Hypoxia (Hypoxemia) 12/2023 - 01/2022
2	Alzheimer Disease (Alzheimer's Disease) 11/2023 - 10/2018
2	Hematologic Neoplasms (Hematological Malignancy) 11/2023 - 08/2015
2	Adenocarcinoma of Lung 01/2023 - 01/2022
2	Rheumatoid Arthritis 03/2022 - 06/2007
2	Anemia 01/2022 - 11/2015
2	Lymphopenia (Lymphocytopenia) 12/2021 - 12/2010
2	Tendon Injuries 06/2021 - 11/2020

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 04/2024 - 12/2010
13	veliparibIBA 01/2023 - 04/2015
10	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 07/2014
9	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 07/2014
9	ErbB Receptors (EGF Receptor)IBA 10/2022 - 10/2015
8	Sirtuin 1IBA 10/2021 - 03/2014
7	Biomarkers (Surrogate Marker)IBA 01/2023 - 03/2011
7	navitoclaxIBA 10/2014 - 12/2010
5	CytokinesIBA 04/2024 - 12/2015
5	RNA (Ribonucleic Acid)IBA 02/2024 - 06/2014
5	Temozolomide (Temodar)FDA LinkGeneric 12/2021 - 07/2017
5	Immunoconjugates (Immunoconjugate)IBA 12/2021 - 05/2017
5	depatuxizumab mafodotinIBA 12/2021 - 12/2017
4	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2023 - 01/2020
4	Therapeutic UsesIBA 12/2023 - 11/2012
4	Messenger RNA (mRNA)IBA 12/2023 - 01/2013
4	EnzymesIBA 12/2022 - 03/2017
4	Cisplatin (Platino)FDA LinkGeneric 10/2021 - 01/2018
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021 - 01/2018
4	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 11/2019 - 01/2018
4	Kanamycin FDA Link 04/2011 - 01/2006
4	AminoglycosidesIBA 04/2011 - 01/2006
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 12/2023 - 01/2016
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 06/2018
3	PlatinumIBA 10/2021 - 01/2018
3	depatuxizumabIBA 01/2021 - 06/2015
3	CreatinineIBA 01/2021 - 01/2017
3	epidermal growth factor receptor VIIIIBA 01/2021 - 10/2015
3	AlbuminsIBA 01/2021 - 10/2015
3	Phosphotransferases (Kinase)IBA 01/2019 - 07/2014
3	ABT-414IBA 01/2018 - 05/2017
2	CurcuminIBA 05/2024 - 01/2023
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2024 - 11/2023
2	HydrogelsIBA 12/2023 - 05/2023
2	Matrix Metalloproteinases (MMPs)IBA 12/2023 - 12/2016
2	CollagenIBA 12/2023 - 02/2021
2	Peptides (Polypeptides)IBA 12/2023 - 03/2011
2	QuercetinIBA 05/2023 - 01/2021
2	InterferonsIBA 04/2023 - 01/2021
2	C-Reactive ProteinIBA 04/2023 - 01/2020
2	Long Noncoding RNAIBA 01/2023 - 01/2019
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2023 - 08/2021
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023 - 01/2019
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 01/2022
2	ChromatinIBA 01/2022 - 07/2014
2	NLR ProteinsIBA 01/2022 - 01/2022
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2021 - 11/2015
2	Alanine Transaminase (SGPT)IBA 12/2021 - 11/2015
2	SolutionsIBA 06/2021 - 05/2015
2	Celecoxib (Celebrex)FDA Link 01/2021 - 01/2021

Therapy/Procedure

15	Drug Therapy (Chemotherapy) 02/2024 - 03/2011
13	Therapeutics 12/2023 - 01/2016
6	Hematopoietic Stem Cell Transplantation 01/2024 - 03/2017
3	Transplantation 02/2024 - 11/2023
3	Operative Surgical Procedures 12/2023 - 05/2020
3	Aftercare (After-Treatment) 12/2020 - 01/2013